Department of Cardiology, Gold Coast Hospital, Level 9, 108 Nerang Street, Southport, Queensland 4215, Australia.
Singapore Med J. 2009 Oct;50(10):949-55.
Coronary artery disease (CAD) is fast becoming a major morbidity and mortality burden in the developing world. The magnitude of the problem is predicted to exceed that of the developed world due to the sheer population numbers at risk. The Indian subcontinental ethnicity has been associated with a more severe form of CAD that has its onset at a younger age. This form of coronary disease and its risk factors seem quite different from what has been previously described in studies done among non-Asian Indian populations (mainly Caucasians living in the West). This fact has led to a situation where the current preventative and management protocols that have worked well in the non-Asian Indian populations, have failed to bring about the anticipated control over this disease condition, its progression and its incidence in this population. The time has come to identify the variant of CAD in the Asian Indian ethnic population and the associated metabolic factors, as a separate and distinct entity, and as a unique syndrome. This distinction may facilitate more focused and ethnicity-specific studies to be carried out to unravel the mysteries surrounding the clinical, pathological and molecular biological aspects of the CAD syndrome among Asian Indian ethnics. The outcomes and findings of such investigations may help gain a stranglehold on this rapidly-progressing disease condition among the populations in emerging and densely-populated economies of the South Asian region, as well as among millions of Asian-Indian ethnics living all over the world. Thus we may brace ourselves to better address or even prevent what has been dubbed "the next major clinical epidemic of our times".
冠状动脉疾病(CAD)在发展中国家迅速成为主要的发病率和死亡率负担。由于处于危险中的人口数量庞大,预计这个问题的规模将超过发达国家。印度次大陆的种族与更严重形式的 CAD 有关,这种 CAD 在更年轻时就开始出现。这种形式的冠心病及其危险因素似乎与之前在非亚洲印度人群(主要是居住在西方的白种人)中进行的研究中所描述的截然不同。这一事实导致了这样一种情况,即在非亚洲印度人群中效果良好的当前预防和管理方案,未能如预期那样控制这种疾病状况、其进展及其在该人群中的发病率。现在是时候将亚洲印度族裔人群中的 CAD 变体及其相关代谢因素确定为一个单独的、不同的实体,并将其作为一个独特的综合征。这种区别可以促进更有针对性和特定于种族的研究,以揭示亚洲印度族裔人群中 CAD 综合征在临床、病理和分子生物学方面的奥秘。这些调查的结果和发现可能有助于控制南亚地区新兴和人口密集经济体以及全球数百万亚洲印度裔人群中这种疾病的迅速发展。因此,我们可以做好准备,更好地应对甚至预防所谓的“我们这个时代的下一个主要临床流行病”。